CAMP4 Therapeutics Corp

Research CAMP4 Therapeutics Corp (CAMP) on Bullrun: market cap USD 230.55M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCAMP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 230.55M
• Financial periodFY2025
• RevenueUSD 3.50M
• Revenue growth436.5%
• Net income-USD 80.40M
• Free cash flow-USD 29.83M

Valuation Snapshot

latest market cap is USD 230.55M.

About CAMP4 Therapeutics Corp

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018.

Frequently asked questions

What is CAMP4 Therapeutics Corp's market cap?

CAMP4 Therapeutics Corp's market capitalization is USD 230.55M.

What does CAMP4 Therapeutics Corp do?

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders.